search
Back to results

Evaluating Piezo-ICSI. - The EPI Study.

Primary Purpose

IVF, Infertility

Status
Suspended
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Piezo-ICSI
Sponsored by
Vitrolife
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for IVF focused on measuring ICSI, Fertilization, Piezo-ICSI, Oocyte, Blastocyst rate

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients receiving controlled ovarian stimulation with gonadotrophins needing ICSI for fertilizing oocytes.
  2. Availability of at least six mature oocytes (MII) after oocyte pick-up.
  3. Planned blastocyst culture.

Exclusion Criteria:

  1. Intention to perform any form of preimplantation genetic testing
  2. The use of IMSI or polarized light in the ICSI process
  3. The use of assisted hatching prior to randomization.
  4. Surgical sperm retrieval (SSR) patients.
  5. Previous participation in this RCT
  6. Concurrent participation in another investigation that can affect the primary outcome of this study.
  7. Sperm sample with <0.1million/ml or motility of <2% after preparation.
  8. Fertility preservation cycles.
  9. If a day 2-4 transfer is planned
  10. Use of vitrified oocytes.

Sites / Locations

  • Nurture Fertility (TFP)
  • Oxford Fertility (TFP)

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

ICSI

Piezo-ICSI

Arm Description

Traditional microinjection (ICSI) is performed on oocytes.

Microinjection (ICSI) is performed using the Piezo-ICSI technique.

Outcomes

Primary Outcome Measures

Fertilization rate
Number of normally fertilized oocytes per injected oocytes

Secondary Outcome Measures

Percentage of degenerated oocytes
Number of oocytes that have degenerated after the procedure
Percentage of 0 PN oocytes
Number of oocytes not fertilized (0 PN) after the procedure.
Percentage of 1 PN oocytes.
Number of oocytes fertilized with one pronuclei (1 PN) after the procedure.
Percentage of >2PN oocytes.
Number of oocytes fertilized with more than 2 pronuclei (>2PN) after the procedure.
Differences in KID scores.
Embryo development will be analysed using a mathematical models called KID (0-10 scale).
Differences in iDA scores.
Embryo development will be analyzed using a artificial intelligence model, called iDA (0-10 scale).
Blastocyst rate (number of grade 3 or higher).
Number of blastocysts with a morphological score of grade 3 or higher.
Percentage of cryopreserved blastocysts on day 5 and 6.
Number of blastocysts cryopreserved on day 5 and day 6.
8. Utilization rate (Number of transferred and cryopreserved blastocysts). Utilization rate
Number of transferred and cryopreserved blastocysts

Full Information

First Posted
December 1, 2020
Last Updated
October 24, 2022
Sponsor
Vitrolife
search

1. Study Identification

Unique Protocol Identification Number
NCT04669652
Brief Title
Evaluating Piezo-ICSI. - The EPI Study.
Official Title
Will Piezo-ICSI Increase Fertilization Rates Compared to Conventional ICSI? A Prospective Randomized Sibling Study.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Suspended
Why Stopped
Study on hold
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vitrolife

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Intracytoplasmic sperm injection (ICSI) has successfully been used to treat both severe male infertility and fertilization failure since its introduction in the early 1990´s. During the procedure a single sperm is injected into the cytoplasm of an oocyte to achieve fertilization. This technique is intrusive, has a relatively long learning curve and variable operator performance. A new injection technique called piezo-ICSI has recently been introduced. During piezo-ICSI, a piezo-electric effect is generated through the conversion of electric energy to mechanical energy. This causes a smooth movement of the injection pipette, which allows for steady, controlled microinjections with less psychical stress applied on the oocytes than by the conventional technique. A recent analysis, based on data from 9 different studies comparing conventional ICSI and piezo-ICSI (17500 cases), showed a benefit of piezo. Unfortunately, proper randomized trials are missing from this analysis. The proposed study is a randomized controlled study carried out at two private IVF clinics. Eligible participants are patients undergoing ICSI treatment, with a minimum of 6 oocytes. The participants will act as their own controls, with their oocytes randomly and equally divided between injection by the investigated and the conventional technique. Whether piezo-ICSI is associated with improved success rates or reduction in adverse outcomes is at present unclear. Patients with fragile oocytes may benefit more from piezo-ICSI. In patients above 35 years, piezo-ICSI has been associated with a lower oocyte degeneration rate and an increased blastocyst rate. The aim of the study is to investigate whether the piezo-ICSI technique will result in more oocytes becoming normally fertilized compared to conventional ICSI. Another proposed benefit of piezo-ICSI lies in the standardization and simplification of the ICSI procedure. Making the injection procedure more independent of operator skill may result in a more robust and predictable laboratory output.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
IVF, Infertility
Keywords
ICSI, Fertilization, Piezo-ICSI, Oocyte, Blastocyst rate

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A sibling study randomizing oocytes to 2 study groups.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
265 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ICSI
Arm Type
No Intervention
Arm Description
Traditional microinjection (ICSI) is performed on oocytes.
Arm Title
Piezo-ICSI
Arm Type
Experimental
Arm Description
Microinjection (ICSI) is performed using the Piezo-ICSI technique.
Intervention Type
Device
Intervention Name(s)
Piezo-ICSI
Intervention Description
During piezo-ICSI, a piezo-electric effect is generated through the conversion of electric energy to mechanical energy. This causes a smooth movement of the injection pipette, which allows for steady, controlled microinjection of a sperm with less psychical stress applied on the oocytes than by the conventional technique.
Primary Outcome Measure Information:
Title
Fertilization rate
Description
Number of normally fertilized oocytes per injected oocytes
Time Frame
Oocytes will be observed over a period of 26 hours after the intervention
Secondary Outcome Measure Information:
Title
Percentage of degenerated oocytes
Description
Number of oocytes that have degenerated after the procedure
Time Frame
Oocytes will be observed over a period of 26 hours after the intervention
Title
Percentage of 0 PN oocytes
Description
Number of oocytes not fertilized (0 PN) after the procedure.
Time Frame
Oocytes will be observed over a period of 26 hours after the intervention
Title
Percentage of 1 PN oocytes.
Description
Number of oocytes fertilized with one pronuclei (1 PN) after the procedure.
Time Frame
Oocytes will be observed over a period of 26 hours after the intervention
Title
Percentage of >2PN oocytes.
Description
Number of oocytes fertilized with more than 2 pronuclei (>2PN) after the procedure.
Time Frame
Oocytes will be observed over a period of 26 hours after the intervention
Title
Differences in KID scores.
Description
Embryo development will be analysed using a mathematical models called KID (0-10 scale).
Time Frame
Embryos will be observed over a period of 6 days after the procedure
Title
Differences in iDA scores.
Description
Embryo development will be analyzed using a artificial intelligence model, called iDA (0-10 scale).
Time Frame
Embryos will be observed over a period of 6 days after the procedure
Title
Blastocyst rate (number of grade 3 or higher).
Description
Number of blastocysts with a morphological score of grade 3 or higher.
Time Frame
Embryos will be observed over a period of 6 days after the procedure
Title
Percentage of cryopreserved blastocysts on day 5 and 6.
Description
Number of blastocysts cryopreserved on day 5 and day 6.
Time Frame
Embryos will be observed over a period of 6 days after the procedure
Title
8. Utilization rate (Number of transferred and cryopreserved blastocysts). Utilization rate
Description
Number of transferred and cryopreserved blastocysts
Time Frame
Embryos will be observed over a period of 6 days after the procedure

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients receiving controlled ovarian stimulation with gonadotrophins needing ICSI for fertilizing oocytes. Availability of at least six mature oocytes (MII) after oocyte pick-up. Planned blastocyst culture. Exclusion Criteria: Intention to perform any form of preimplantation genetic testing The use of IMSI or polarized light in the ICSI process The use of assisted hatching prior to randomization. Surgical sperm retrieval (SSR) patients. Previous participation in this RCT Concurrent participation in another investigation that can affect the primary outcome of this study. Sperm sample with <0.1million/ml or motility of <2% after preparation. Fertility preservation cycles. If a day 2-4 transfer is planned Use of vitrified oocytes.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Scott Nelson, MD, PhD
Organizational Affiliation
University of Glasgow
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nurture Fertility (TFP)
City
Nottingham
ZIP/Postal Code
NG10 5QG
Country
United Kingdom
Facility Name
Oxford Fertility (TFP)
City
Oxford
ZIP/Postal Code
OX4 2HW
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluating Piezo-ICSI. - The EPI Study.

We'll reach out to this number within 24 hrs